Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best biotech stocks to buy. Vertex Pharmaceuticals ...
Citi raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $575 from $550 and keeps a Buy rating on the shares. The firm upped the ...